Annual report [Section 13 and 15(d), not S-K Item 405]

Note 3 - Summary of Significant Accounting Policies (Details Textual)

v3.25.1
Note 3 - Summary of Significant Accounting Policies (Details Textual)
 12 Months Ended
Apr. 11, 2023
$ / shares
shares
Apr. 05, 2023
USD ($)
$ / shares
shares
Dec. 31, 2024
USD ($)
$ / shares
Dec. 31, 2023
USD ($)
$ / shares
Common Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares     $ 0.0001 $ 0.0001
Proceeds from Issuance of Common Stock     $ 0 $ 6,000,000
Number of Operating Segments     2  
Number of Reportable Segments     2  
Cash, FDIC Insured Amount     $ 250,000  
Cash, Uninsured Amount     2,400,000  
Contract with Customer, Liability     89,000 42,000
Advertising Expense     200,000 200,000
Depreciation     $ 768,000 $ 758,000
Impairment, Intangible Asset, Statement of Income or Comprehensive Income [Extensible Enumeration]     Asset Impairment Charges  
Healthcare Operations [Member]        
Impairment of Intangible Assets (Excluding Goodwill)     $ 12,800,000  
Trade Names and Customer Contracts [Member]        
Finite-Lived Intangible Asset, Useful Life (Year)     10 years  
Closing Rate [Member]        
Foreign Currency Exchange Rate, Translation     1.26 1.27
Yearly Average Rate [Member]        
Foreign Currency Exchange Rate, Translation     1.28 1.24
Maximum [Member]        
Cash, FDIC Insured Amount     $ 250,000  
April 2023 Private Placement [Member]        
Stock Issued During Period, Shares, New Issues (in shares) | shares 3,428,571 3,428,571    
Common Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares $ 0.0001 $ 0.0001    
Shares Issued, Price Per Share (in dollars per share) | $ / shares $ 1.75 $ 1.75    
Proceeds from Issuance of Common Stock   $ 6,000,000